CPHI Milan newsletter
PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

CDMO Subsection

Insights into the latest developments in CDMO services and manufacturing.

Continue reading

Injectables Subsection

Expert perspectives on the evolving needs of injectable therapies and packaging.

Continue reading

Nasal & Pulmonary Subsection

Exploring the latest developments in inhalation technologies, respiratory delivery and sustainability

Continue reading

Advertisement

CPHI Milan
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Lifecore Biomedical

Advertisement

Solstice

Tamper-evidence – A Vital Matter of Safet

This article, written by Alessio Bressan at IGGB and starting from the concept of falsified medicine as postulated in the European directive, focuses on the options actually on the market concerning tamper-evident systems. It closes by demonstrating how a system integrated in the outer packaging and completely mechanical is able to improve the safety of the outer packaging and protect it against counterfeit attempts in an effective way.
https://international-pharma.com/wp-content/uploads/2016/01/Tamper-evidence.pdf

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Tjoapack
Aptar – 08/01/2026